# Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer

> **NCT06482658** · NA · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 380 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** Transrectal perilesional/regional systematic biopsy (PB/RSB)
- **PROCEDURE:** Combination of transrectal systematic biopsy and targeted biopsy

## Key facts

- **NCT ID:** NCT06482658
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-12
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 380 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06482658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06482658, "Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06482658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*